About Dispersol Tech
Dispersol Tech is a Healthcare company based in Georgetown (United States) founded in 2007. It operates as a solid dispersion technology for pharmaceutical solubility enhancement is developed. The company has 54 employees. Its chief executive is Edward Rudnic. Its focus areas include Biopharma Outsourcing, CDMO, Small Molecules & Peptides and Formulation. Its legal entity is DISPERSOL TECHNOLOGIES, LLC. Its competitors include Unither, Akums, Jubilant Life Sciences, Recipharm and CoreRx and 3 more; 4 of its 8 listed competitors have raised funding.
Company details
DisperSol Technologies evolved from a research collaboration with the College of Pharmacy at The University of Texas at Austin. It provides expertise in formulation and processing technologies for solubilitybioavailability enhancement of poorly water-soluble drug molecules. The companys proprietary KinetiSol technology is based on a commercial plastic compounding process that is cGMP compliant. The company claims that it has advantages over spray drying and hot melt extrusion for highly insoluble drugs. DisperSol offers a variety of services including formulationprocess research and development for fusion and solvent-based processes, solid-state and chemical characterization, accelerated stability testing, in-vitroin-vivo performance analysis, drug product manufacturing for pre-clinical and early-phase clinical studies, as well as formulation and process development consulting.
- Headquarters Georgetown, United States
- Employees 54
- SectorsHealthcare
- Website dispersoltech.com
- Social LinkedIn
- Legal Name Dispersol Technologies, Llc
- Employee Count54
People of Dispersol Tech
6 people are tracked at Dispersol Tech (5 in leadership, 1 in team); the tracked headcount is 54.
| Name | Role | Group |
|---|---|---|
Edward Rudnic | CEO | Leadership |
Tim Scott | President, CEO & Board Member | Leadership |
Elizabeth Hickman | Chief Business Officer | Leadership |
Dave A. Miller | Chief Scientific Officer | Leadership |
Chris Brough | Chief Technology Officer | Leadership |
Justin M. Keen | SVP, Operations | Team |
Complete people profiles for Dispersol Tech
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Competitors of Dispersol Tech
Dispersol Tech has 8 listed competitors in our database, 4 of them funded. They include Unither, Akums, Jubilant Life Sciences, Recipharm and CoreRx, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| unither-pharma.com | 1993 | Paris, France | – | – | Contract development and manufacturing organization for proprietary and generic drugs | |
| akums.in | 2004 | Delhi, India | $70M | 395 | CDMO focusing on spectrum of dosage forms and therapeutic segments | |
| jubl.com | 1978 | Noida, India | – | – | Company offering a suite of R&D and manufacturing services for small molecules and generics | |
| recipharm.com | 1995 | Jordbro, Sweden | – | 1,083 | Pharmaceutical development and manufacturing services are offered contractually. | |
| corerxpharma.com | 2006 | Clearwater, United States | $15M | – | CDMO with a focus on early phase drug product development | |
| neclife.com | 1995 | Chandigarh, India | $46.85M | 175 | Cephalosporin APIs and generic formulations are manufactured. | |
| windlas.com | 2001 | Gurugram, India | $12.96M | 1,264 | Biopharma regulatory affairs, quality control, and strategy services are provided. | |
| medpharm.com | 1998 | Guildford, United Kingdom | – | 108 | Topical and inhaled drug delivery formulations are developed and manufactured. |
Detailed competitors of Dispersol Tech
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
10 companies that operate in the same segment as Dispersol Tech (Biopharma Outsourcing & Drug Delivery), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 1,820 | |
Drug discovery and development services are provided to biopharma sector. | 1993 | Hamburg, Hamburg, Germany | USD 25 M | USD 926.33 M | 4,830 | |
Drug discovery and development services for small molecules are provided. | 2003 | Beijing, China | USD 320 M | – | 476 | |
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 12,470 | |
Pharmaceutical products for treating multiple diseases are provided. | 1849 | New York, New York, United States | USD 8 M | USD 266.99 M | 1,770 | |
Provider of laboratory tests for physicians | 1969 | Burlington, Vermont, United States | – | USD 13.95 B | 70,000 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 4,260 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Dispersol Tech
Complete news archive for Dispersol Tech
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Dispersol Tech
Dispersol Tech was founded in 2007.
Dispersol Tech is headquartered in Georgetown, United States.
Edward Rudnic is the current CEO of Dispersol Tech.
Dispersol Tech has 54 employees.
DisperSol Technologies evolved from a research collaboration with the College of Pharmacy at The University of Texas at Austin. It provides expertise in formulation and processing technologies for solubilitybioavailability enhancement of poorly water-soluble drug molecules. The companys proprietary KinetiSol technology is based on a commercial plastic compounding process that is cGMP compliant. The company claims that it has advantages over spray drying and hot melt extrusion for highly insoluble drugs. DisperSol offers a variety of services including formulationprocess research and development for fusion and solvent-based processes, solid-state and chemical characterization, accelerated stability testing, in-vitroin-vivo performance analysis, drug product manufacturing for pre-clinical and early-phase clinical studies, as well as formulation and process development consulting.
Dispersol Tech's top competitors include Jubilant Life Sciences, Akums and Nectar Lifesciences.
Dispersol Tech operates through Dispersol Technologies, Llc.